
T3 Molecular Genetics develops therapeutics for inflammatory and infectious diseases. It uses immune cell modulation technology across a multidisciplinary team. Core tech includes therapeutically bioactive peptomers and small molecules as Treg modulators, with AI and ML driving drug discovery. As a seed-stage Bengaluru company, it targets healthcare providers, pharmaceutical firms, and research institutions.

T3 Molecular Genetics develops therapeutics for inflammatory and infectious diseases. It uses immune cell modulation technology across a multidisciplinary team. Core tech includes therapeutically bioactive peptomers and small molecules as Treg modulators, with AI and ML driving drug discovery. As a seed-stage Bengaluru company, it targets healthcare providers, pharmaceutical firms, and research institutions.